Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Case Reports in Ophthalmology|April 20, 2011
Outer retinal microstructure in a case of acute idiopathic blind spot enlargement syndromeMichitaka Sugahara, Kei Shinoda, Soiti Celso Matsumoto, et al.Journal of Vision|March 8, 2012
Stiles-Crawford effect in focal macular ERGs from macaque monkeyCelso Soiti Matsumoto, Kei Shinoda, Harue Matsumoto, et al.Retinal Cases & Brief Reports|November 13, 2014
Valsalva retinopathy developing during Japanese cheerleading training ("ouendan")Gen Hanazono, Kei Shinoda, Minoru Obazawa, et al.Investigative Ophthalmology & Visual Science|March 13, 2009
Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activationShunsuke Kubota, Toshihide Kurihara, Hiroshi Mochimaru, et al.Investigative Ophthalmology & Visual Science|April 4, 2008
Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthinKanako Izumi-Nagai, Norihiro Nagai, Kazuhiro Ohgami, et al.The American Journal of Pathology|November 1, 2008
(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin systemShingo Satofuka, Atsuhiro Ichihara, Norihiro Nagai, et al.Diabetes|April 25, 2009
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammationShingo Satofuka, Atsuhiro Ichihara, Norihiro Nagai, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2007
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularizationKanako Izumi-Nagai, Norihiro Nagai, Kazuhiro Ohgami, et al.Investigative Ophthalmology & Visual Science|April 27, 2007
Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykininNorihiro Nagai, Yuichi Oike, Kanako Izumi-Nagai, et al.Investigative Ophthalmology & Visual Science|August 29, 2007
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathwayNorihiro Nagai, Kanako Izumi-Nagai, Yuichi Oike, et al.Pageof 3